Dr. Sergey Ayzenberg, MD

Dr. Ayzenberg practices at Maimonides Cardiology Outpatient C - HOPD in Brooklyn, New York.

Dr. Ayzenberg's NPI, 1306031125, was assigned on September 14, 2007. Dr. Ayzenberg graduated from Ross University School of Medicine in 2002. Dr. Ayzenberg holds New York license 236793.

Dr. Ayzenberg's primary practice is Maimonides Cardiology Outpatient C - HOPD, at 421 Ocean Pkwy, Brooklyn, NY 11218.

Dr. Ayzenberg's primary practice is Maimonides Cardiology Outpatient C - HOPD in Brooklyn, New York. Dr. Ayzenberg is also affiliated with Maimonides Medical Center. The medical group on file is Maimonides Medical Center. Dmand AI also links Dr. Ayzenberg to 1 more hospital, 1 home health agency and 1 medical group, each named with a free account. Dr. Ayzenberg's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ayzenberg practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Ayzenberg's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Ayzenberg is board certified in interventional cardiology by the American Board of Internal Medicine. Dr. Ayzenberg is licensed in New York.

Dmand AI lists aneurysm, angioplasty, atrial fibrillation and flutter, cardiac arrhythmia, cardiac catheterization, cardiomyopathy, cerebrovascular disease and chronic hypertension among the conditions Dr. Ayzenberg treats.

CMS data shows 3,166 Medicare services from Dr. Ayzenberg across 15 procedure codes in 2024, for 1,092 Medicare patients. Medicare paid $205,312 for them.

CMS counts 1,092 Medicare patients who saw Dr. Ayzenberg in 2024. The largest group is 75 to 84, with 455 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 66% are also on Medicaid. Their average risk score is 1.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ayzenberg's median patient age at 75, with 42% women.

In 2024, Dr. Ayzenberg wrote 6,958 Medicare Part D claims for 583 patients. 79% of them were for generic drugs. CMS names the drug for 6,667 of them, across 72 drugs with 11 or more claims each, at $915,553 in total drug cost. In 2023, CMS named 7,519 claims across 77 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Ayzenberg for performance year 2024, reported through an alternative payment model (APM). Dr. Ayzenberg accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 62 procedures of coronary angioplasty and stenting by Dr. Ayzenberg, more than 89% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 20 papers to Dr. Ayzenberg, published from 2014 to 2025. 2020 was the busiest year, with 6. The most frequent topics are Coronary Angiography, Cardiac Catheterization and Platelet Aggregation Inhibitors. Dr. Ayzenberg has published most often in Cureus. Dr. Ayzenberg's most frequent co-authors are Jacob Shani, MD, Robert Frankel, MD and Sunny Goel, MD.

Dmand AI links Dr. Ayzenberg to 1 clinical trial. Conditions studied include Arterial Occlusive Diseases and Vascular Diseases.

CMS Open Payments shows 1,065 general payments to Dr. Ayzenberg from 43 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 67% of the total. Amgen Inc. paid the most, $132,211.

Dmand AI lists 2 awards for Dr. Ayzenberg.

Dr. Ayzenberg graduated from Ross University School of Medicine in 2002. Dr. Ayzenberg is a member of ACC.

Dr. Ayzenberg is in network with 16 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.